Can a single injection stop scars? new trial aims to find out
NCT ID NCT07488988
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase 2 trial tests whether verteporfin, a drug injected into the skin during tummy tuck surgery, can reduce scar formation. Twelve adults will receive different doses of verteporfin and a placebo in separate parts of their surgical wound. Researchers will compare scar appearance after 3 months using a standard rating scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- verteporfin
- What this could lead to
- If it works, this could point toward a simple injection to prevent or reduce scarring after surgery.
- What could go wrong
- This is a very small early-phase trial with only 12 people. The effect may be small or not work at all, and there could be side effects like injection reactions or delayed healing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL SCAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Odense University Hospital
Odense, 5000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.